Ana Barajas

Dr. Ana Barajas

Autonomous University of Barcelona, Cerdanyola del Vallès, Spain
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
Ana BarajasAna Barajas
Ana Barajas
Susana OchoaSusana Ochoa
Susana Ochoa
JOJordi E Obiols
Jordi E Obiols
LLLluís Lalucat-Jo
Lluís Lalucat-Jo
Introduction. To date, few studies have focused on the characterization of clinical phenomenology regarding gender in population at high‐risk of psychosis. This paper is an attempt to summarize the findings found in the scientific literature regarding gender differences in high‐risk populations, taking into account parameters studied in populations with schizophrenia and other psychotic disorders, such as incidence, clinical expression, duration of untreated illness (DUI), social functioning, and cognitive impairment prior to full‐blown psychosis development. Method. Studies were systematically searched in PubMed. Studies using gender variable as a control variable were excluded. 12 studies met inclusion criteria. Results. Most of the studies found a differential pattern between women and men as regards clinical, social, and cognitive variables in the prodromal phase, with worse performance in men except in cognitive functioning (more severe negative symptoms, worse social functioning, and longer DUI in men). Similar conversion rates over time were found between men and women. Conclusions. Many of the studies analyzed suggest that differences between men and women in the expression of psychosis extend across a continuum, from the subclinical forms of illness to the debut of psychosis. However, the small number of studies and their significant methodological and clinical limitations do not allow for firm conclusions.

7 February 2017 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
Susana OchoaSusana Ochoa
Susana Ochoa
RLR. López-Carrilero
R. López-Carrilero
MBMaria Luisa Barrigon
Maria Luisa Barrigon
EPEsther Pousa
Esther Pousa
Ana BarajasAna Barajas
Ana Barajas
TGthe Spanish Metacognition Study Group
the Spanish Metacognition Study Group
Background: Aims were to assess the efficacy of metacognitive training (MCT) in people with a recent onset of psychosis in terms of symptoms as a primary outcome and metacognitive variables as a secondary outcome.Method: A multicenter, randomized, controlled clinical trial was performed. A total of 126 patients were randomized to an MCT or a psycho-educational intervention with cognitive-behavioral elements. The sample was composed of people with a recent onset of psychosis, recruited from nine public centers in Spain. The treatment consisted of eight weekly sessions for both groups. Patients were assessed at three time-points: baseline, post-treatment, and at 6 months follow-up. The evaluator was blinded to the condition of the patient. Symptoms were assessed with the PANSS and metacognition was assessed with a battery of questionnaires of cognitive biases and social cognition.Results: Both MCT and psycho-educational groups had improved symptoms post-treatment and at follow-up, with greater improvements in the MCT group. The MCT group was superior to the psycho-educational group on the Beck Cognitive Insight Scale (BCIS) total (p= 0.026) and self-certainty (p= 0.035) and dependence self-subscale of irrational beliefs, comparing baseline and post-treatment. Moreover, comparing baseline and follow-up, the MCT group was better than the psycho-educational group in self-reflectiveness on the BCIS (p= 0.047), total BCIS (p= 0.045), and intolerance to frustration (p= 0.014). Jumping to Conclusions (JTC) improved more in the MCT group than the psycho-educational group (p= 0.021). Regarding the comparison within each group, Theory of Mind (ToM), Personalizing Bias, and other subscales of irrational beliefs improved in the MCT group but not the psycho-educational group (p< 0.001–0.032).Conclusions: MCT could be an effective psychological intervention for people with recent onset of psychosis in order to improve cognitive insight, JTC, and tolerance to frustration. It seems that MCT could be useful to improve symptoms, ToM, and personalizing bias.

27 November 2020 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
Irene BirulésIrene Birulés
Irene Birulés
RLRaquel López-Carrilero
Raquel López-Carrilero
DCDaniel Cuadras
Daniel Cuadras
EPEsther Pousa
Esther Pousa
MBMaria Luisa Barrigon
Maria Luisa Barrigon
Susana OchoaSusana Ochoa
Susana Ochoa
Background: Metacognitive training (MCT) has demonstrated its efficacy in psychosis. However, the effect of each MCT session has not been studied. The aim of the study was to assess changes in cognitive insight after MCT: (a) between baseline, post-treatment, and follow-up; (b) after each session of the MCT controlled for intellectual quotient (IQ) and educational level. Method: A total of 65 patients with first-episode psychosis were included in the MCT group from nine centers of Spain. Patients were assessed at baseline, post-treatment, and 6 months follow-up, as well as after each session of MCT with the Beck Cognitive Insight Scale (BCIS). The BCIS contains two subscales: self-reflectiveness and self-certainty, and the Composite Index. Statistical analysis was performed using linear mixed models with repeated measures at different time points. Results: Self-certainty decreased significantly (p = 0.03) over time and the effect of IQ was negative and significant (p = 0.02). From session 4 to session 8, all sessions improved cognitive insight by significantly reducing self-certainty and the Composite Index. Conclusions: MCT intervention appears to have beneficial effects on cognitive insight by reducing self-certainty, especially after four sessions. Moreover, a minimum IQ is required to ensure benefits from MCT group intervention.

1 January 2015 in Comprehensive Psychiatry
Verified
Journal Article
Closed access
SLSerafín Lemos-Giráldez
Serafín Lemos-Giráldez
LGLeticia García-Alvarez
Leticia García-Alvarez
MPMercedes Paino
Mercedes Paino
Eduardo Fonseca-PedreroEduardo Fonseca-Pedrero
Eduardo Fonseca-Pedrero
OVOscar Vallina-Fernández
Oscar Vallina-Fernández
RARetta Andresen
Retta Andresen

1 December 2015 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
CNChristian Núñez
Christian Núñez
GGGENIPE Group
GENIPE Group
Susana OchoaSusana Ochoa
Susana Ochoa
EHElena Huerta-Ramos
Elena Huerta-Ramos
IBIris Baños
Iris Baños
JUJudith Usall
Judith Usall

1 August 2016 in Psychiatry Research
Verified
Journal Article
Closed access
NGNorma Grau
Norma Grau
ERElena Rubio-Abadal
Elena Rubio-Abadal
JUJudith Usall
Judith Usall
Ana BarajasAna Barajas
Ana Barajas
ABAnna Butjosa
Anna Butjosa
SOSusana Ochoa
Susana Ochoa